Global Bowen Disease Treatment Market – Impact of Coronavirus (Covid-19) Pandemic
Coronavirus (COVID-19) outbreak was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared COVID-19, as pandemic on March 11, 2020. According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 252,826,597 cases and 5,092,761 deaths due to coronavirus (COVID-19) were reported till November 14, 2021, across the globe.
The COVID-19 pandemic and lockdown in various countries across the globe has negatively impacted the financial status of businesses across all sectors. The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry mainly due to strict lockdown in several regions. Likewise, COVID-19 pandemic is expected to have a negative impact on the global Bowen disease treatment market over the forecast period, owing to disruption in cancer treatment services and halt of clinical trials related to treatment of cancer (including Bowen disease). For instance, according to a report published by the World Health Organization in July 2020, around 42% of the countries across the world have disrupted services for cancer treatment in lieu of COVID-19 pandemic.
Global Bowen Disease Treatment Market Restraint
The side effects of chemotherapy drugs used in the treatment of Bowen disease are the factors that are expected to hinder growth of the global Bowen disease treatment market over the forecast period. For instance, according to an article published by the StatPearls journal in July 2021, topical application of fluorouracil, a chemotherapy drug used for treatment of Bowen disease is associated with adverse effects such as pain, crusting, erythema, and others.
Bowen Disease Treatment Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients